E-LIB Suche - Ergebnisse für: Berger, Zdenek

1

A Post-Marketing Surveillance Study of Nusinersen for Spina..:

Jiang, Yuwu ; Wang, Yi ; Xiong, Hui...
Advances in Therapy. 41 (2024) 7 - p. 2743-2756 , 2024

Link: https://doi.org/10.1007/..

2

Continued benefit of nusinersen initiated in the presymptom..:

Crawford, Thomas O. ; Swoboda, Kathryn J. ; De Vivo, Darryl C....
Muscle & Nerve. 68 (2023) 2 - p. 157-170 , 2023

Link: https://doi.org/10.1002/..

3

Nusinersen Treatment of Children with Later-Onset Spinal Mu..:

Dunaway Young, Sally ; Montes, Jacqueline ; Glanzman, Allan M....
Journal of Clinical Medicine. 12 (2023) 15 - p. 4901 , 2023

Link: https://doi.org/10.3390/..

4

Baseline Characteristics and Interim Safety in RESPOND: A P..:

Kuntz, Nancy ; Parsons, Julie ; Brandsema, John F....
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

5

A pediatric quantitative systems pharmacology model of neur..:

Paris, Alessio ; Bora, Pranami ; Parolo, Silvia...
CPT: Pharmacometrics & Systems Pharmacology. 12 (2022) 2 - p. 196-206 , 2022

Link: https://doi.org/10.1002/..

6

Restoration of Nusinersen Levels Following Treatment Interr..:

MacCannell, Drew ; Berger, Zdenek ; Kirschner, Janbernd...
CNS Drugs. 36 (2022) 2 - p. 181-190 , 2022

Link: https://doi.org/10.1007/..

7

Corrigendum to 'Population pharmacokinetics-based recommend..:

MacCannell, Drew ; Berger, Zdenek ; East, Lilly...
Neuromuscular Disorders. 32 (2022) 1 - p. e1 , 2022

Link: https://doi.org/10.1016/..

8

Scientific rationale for a higher dose of nusinersen:

Finkel, Richard S. ; Ryan, Monique M. ; Pascual Pascual, Samuel Ignacio...
Annals of Clinical and Translational Neurology. 9 (2022) 6 - p. 819-829 , 2022

Link: https://doi.org/10.1002/..

9

Baseline Characteristics and Initial Safety Results in RESP..:

Brandsema, John ; Parsons, Julie ; Proud, Crystal...
Neurology. 98 (2022) 18_supplement - p. , 2022

Link: https://doi.org/10.1212/..

10

Population pharmacokinetics-based recommendations for a sin..:

MacCannell, Drew ; Berger, Zdenek ; East, Lilly...
Neuromuscular Disorders. 31 (2021) 4 - p. 310-318 , 2021

Link: https://doi.org/10.1016/..

11

Escalating Dose and Randomized, Controlled Study of Nusiner..:

Day, John W. ; Pascual, Samuel Ignacio Pascual ; Finkel, Richard S....
Neurology. 96 (2021) 15_supplement - p. , 2021

Link: https://doi.org/10.1212/..

12

Tool Compounds Robustly Increase Turnover of an Artificial ..:

Berger, Zdenek ; Perkins, Sarah ; Ambroise, Claude...
PLOS ONE. 10 (2015) 3 - p. e0119141 , 2015

Link: https://doi.org/10.1371/..

13

Inhibition of glucosylceramide synthase stimulates autophag..:

Shen, Wei ; Henry, Anastasia G. ; Paumier, Katrina L....
Journal of Neurochemistry. 129 (2014) 5 - p. 884-894 , 2014

Link: https://doi.org/10.1111/..

14

Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl..:

Henderson, Jaclyn L. ; Kormos, Bethany L. ; Hayward, Matthew M....
Journal of Medicinal Chemistry. 58 (2014) 1 - p. 419-432 , 2014

Link: https://doi.org/10.1021/..

15

Kinase domain inhibition of leucine rich repeat kinase 2 (L..:

Galatsis, Paul ; Henderson, Jaclyn L. ; Kormos, Bethany L....
Bioorganic & Medicinal Chemistry Letters. 24 (2014) 17 - p. 4132-4140 , 2014

Link: https://doi.org/10.1016/..